EUVIMEDEUVIMED entdecken
Open Access

Adrenocortical carcinoma as a manifestation of Birt–Hogg–Dubé syndrome

Katherine I Wolf iD, Jenae Osborne, Antonio M Lerario, Josh N Vo, Oksana Hamidi, Mouhammed Amir Habra, Gary Hammer, Tobias Else

Endocrine-Related Cancer · 01.03.2026 · 33 (3)

DOI: 10.1530/erc-25-0285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine-Related Cancer, online erschienen am 16.03.2026. Verfasst von Katherine I Wolf und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Metabolism, Endocrinology, & Diabetes, Endocrine Oncology Program, Michigan Medicine, Ann Arbor, Michiga…. Hauptthemen laut MEDLINE: Birt-Hogg-Dube Syndrome, Adrenocortical Carcinoma, Adrenal Cortex Neoplasms. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Birt–Hogg–Dubé syndrome (BHDS) is characterized by fibrofolliculomas, trichodiscomas, renal tumors, lung cysts, and spontaneous pneumothoraces. Other than renal cell carcinoma, no cancers have been confirmed as part of the BHDS tumor spectrum. Here, we set out to uncover if adrenocortical carcinoma (ACC) is associated with BHDS. A retrospective review at a single tertiary care center between 2010 and 2024 was performed using search terms describing the clinical manifestations of BHDS, adrenal tumors, and iterations thereof. The initial review identified 1,010 patients with ACC. Of these patients, 466 were evaluated by a genetic counselor, and 346 underwent genetic testing—seven of which were found to have either characteristic clinical features of BHDS or a confirmed diagnosis. The literature review over the same time period demonstrated five additional cases of malignant adrenal tumors in patients with BHDS. We observed BHDS, confirmed by a pathogenic FLCN variant in 0.7% of all ACC patients, or 1.5% of patients evaluated by a genetic counselor and 2.0% of all patients who underwent genetic testing. Testing for FLCN pathogenic variants should be considered during routine genetic evaluation of patients with ACC, and special attention should be paid to adrenal tumors in BHDS patients during surveillance for renal neoplasms as more than 50% of patients in this series developed metastatic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Birt-Hogg-Dube SyndromeAdrenocortical CarcinomaAdrenal Cortex NeoplasmsHumansFemaleTumor Suppressor ProteinsMaleRetrospective StudiesProto-Oncogene ProteinsMiddle AgedAdultAgedYoung AdultAdolescent

Stichwörter der Autor:innen

Birt–Hogg–Dubéadrenocortical carcinomagenetic syndromeprevalence

Substanzen

FLCN protein, humanTumor Suppressor ProteinsProto-Oncogene Proteins

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Metabolism, Endocrinology, & Diabetes, Endocrine Oncology Program, Michigan Medicine, Ann Arbor, Michigan, USA.
  • Department of Internal Medicine, Division of Genetic Medicine, Michigan Medicine, Ann Arbor, Michigan, USA.
  • Department of Pathology, Michigan Medicine, Ann Arbor, Michigan, USA.
  • Division of Endocrinology and Metabolism, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Endocrine Neoplasia & Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: Katherine I Wolf

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Wolf, K. I., Osborne, J., Lerario, A. M., Vo, J. N., Hamidi, O., Habra, M. A., Hammer, G., & Else, T. (2026). Adrenocortical carcinoma as a manifestation of Birt–Hogg–Dubé syndrome. Endocrine-Related Cancer, 33(3). https://doi.org/10.1530/erc-25-0285

Vancouver

Wolf KI, Osborne J, Lerario AM, Vo JN, Hamidi O, Habra MA, et al. Adrenocortical carcinoma as a manifestation of Birt–Hogg–Dubé syndrome. Endocrine-Related Cancer. 2026;33(3). doi:10.1530/erc-25-0285

BibTeX
@article{Wolf2026,
  author = {Wolf, Katherine I and Osborne, Jenae and Lerario, Antonio M and Vo, Josh N and Hamidi, Oksana and Habra, Mouhammed Amir and Hammer, Gary and Else, Tobias},
  title = {Adrenocortical carcinoma as a manifestation of Birt–Hogg–Dubé syndrome},
  journal = {Endocrine-Related Cancer},
  year = {2026},
  volume = {33},
  number = {3},
  doi = {10.1530/erc-25-0285}
}
Kostenlos starten →